Immix Biopharma (IMMX) Total Current Liabilities (2020 - 2026)
Immix Biopharma's Total Current Liabilities was $9.3 million in Q2 2026, down 7.1% from $10.01 million a year earlier and down 11.7% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Total Current Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2025, Total Current Liabilities at Immix Biopharma came in at $10.11 million, up 16.4% from FY2024.
- Total Current Liabilities has now increased for four consecutive years, with a five-year compound annual growth rate of 13.9% (FY2020 to FY2025).
- In earlier years, Total Current Liabilities was $8.69 million in FY2024 (+133.4%), $3.72 million in FY2023 (+192.3%), $1.27 million in FY2022 (+530.2%) and $202,039 in FY2021 (-96.2%).
- The Q2 2026 figure marks the lowest quarterly Total Current Liabilities since Q4 2024.
- Compared with a year earlier, Total Current Liabilities was higher in seven of the last eight quarters, with growth averaging 71.8%.
- The best year-over-year quarter for Total Current Liabilities over five years was Q4 2022 (growth of 530.2%); the worst was Q4 2021 (a decline of 96.2%).
- Per Business Quant data, IMMX's Total Current Liabilities in the three quarters before Q2 2026 was $10.54 million (Q1 2026), $10.11 million (Q4 2025) and $10.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Immix Biopharma | 820.51 Mn | 820.51 Mn | - | 9.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.30 Mn |
| Mar 31, 2026 | 10.54 Mn |
| Dec 31, 2025 | 10.11 Mn |
| Sep 30, 2025 | 10.85 Mn |
| Jun 30, 2025 | 10.01 Mn |
| Mar 31, 2025 | 9.31 Mn |
| Dec 31, 2024 | 8.69 Mn |
| Sep 30, 2024 | 6.56 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | 5.66 Mn |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 646,457.00 |
| Jun 30, 2022 | 977,209.00 |
| Mar 31, 2022 | 365,086.00 |
| Dec 31, 2021 | 202,039.00 |
| Dec 31, 2020 | 5.27 Mn |
API Access
Immix Biopharma Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();